Lyceft TZ injection contains ceftriaxone + Tazobactam a combination of cephalosporin and betalactamase inhibitor, Indicated for community acquried infection & Respiratory tract infections,Ceftriaxone + Tazobactam combination offers 94.6% efficacy against resistance to ceftriaxone alone.
This medicine is used for the treatment of infections caused by susceptible bacterial species that are resistant to commonly-used systemic antibiotics or ceftriaxone alone. These infections may include urinary tract infections, bone and joint infections, intra-abdominal infections, bacterial septicemia, pelvic inflammatory disease, etc.